National Advocacy Archive

Find testimony, comments, letters, and legal briefs the American Lung Association has submitted to Congress and federal agencies in support of our public policy agenda.

Jan 04, 2019

Health Partner Comments to HHS Re: VA 1115 Waiver (January 4, 2019)

Dec 31, 2018

American Lung Association comments to CMS re: International Price Index Model for Medicare Part B Drugs

Dec 27, 2018

American Lung Association comments to the Departments of HHS, Treasury and Labor re: Health Reimbursement Arrangements and Other Accounts-Based Group Health Plans (CMS-9918-P)

Dec 20, 2018

Letter to FDA Commissioner Gottlieb regarding CDER Reform

Dec 18, 2018

Health Partner Comments Re: 1332 Guidance (December 18, 2018)

Dec 18, 2018

Health Partner Letter to Secretary Azar et al. Re: 1332 Guidance (December 18, 2018)

Dec 17, 2018

Lung Association and other health organizations comments to EPA on proposed rule changes to the emissions standards for new, reconstructed, and modified oil and natural gas sources

Dec 17, 2018

Lung Association and others correct Industry and State petitioners' inaccurate claims in challenges to ozone air quality standard

Dec 17, 2018

Lung Association and others respond to Industry and State petitioners' challenges to ozone air quality standard

Dec 11, 2018

American Lung Association Comments to EPA on the draft PM ISA

Next

No upcoming events near you